MMedXYNews
Ask AIHomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY News/Ophthalmology

Section

Ophthalmology

288 articles

Ask AI
All specialtiesOphthalmologynewsClinical UpdatesCardiologyOncology

Latest updates

news

FAc Intravitreal Implant Achieves Comparable Visual Outcomes with 53% Fewer Injections in Diabetic Macular Edema: Phase 4 NEW DAY Study

The Phase 4 NEW DAY study demonstrates that fluocinolone acetonide (FAc) 0.19 mg implant as baseline therapy achieves similar visual acuity and anatomical improvements compared to aflibercept in diabetic macular edema patients, while signif

Apr 2, 2026
Neurology

Why the New MS Diagnostic Criteria Require Caution: High Frequency of MOGAD and NMOSD in Optic Neuritis Patients

A retrospective study reveals that 24% of patients meeting the latest MS criteria following optic neuritis actually have MOGAD or NMOSD, emphasizing the need for antibody testing to prevent misdiagnosis.

Mar 30, 2026
news

Microvascular Dropout and Parapapillary Atrophy Progression Predict Structural Optic Disc Damage in Glaucoma Suspects

A 19-year retrospective study reveals that microvascular dropout and β-zone parapapillary atrophy progression are powerful independent predictors of structural optic disc damage in glaucoma suspects, even when visual fields remain stable.

Mar 30, 2026
news

Seeing the Invisible: New Global Consensus on Using Advanced Imaging to Track Uveitis Activity

A global task force has established new standardized imaging measures to define disease activity in non-infectious posterior uveitis, bridging a critical gap in clinical diagnosis and trial monitoring.

Mar 24, 2026
Clinical Updates

Predictive Value of Early Fluid Resolution for Long-term Durability of Faricimab in Neovascular Age-Related Macular Degeneration: A Synthesis of Evidence

This review synthesizes clinical trial data demonstrating that rapid resolution of retinal fluid by week 12 with faricimab significantly predicts long-term treatment durability in patients with neovascular age-related macular degeneration.

Mar 24, 2026
news

Predicting Ocular Relapse in Sarcoid Uveitis: Macular Edema and Baseline Inflammation as Critical Prognostic Markers

A multicentric study of 336 patients reveals that two-thirds of sarcoid uveitis cases experience relapse, primarily driven by baseline macular edema and persistent inflammation. Despite high recurrence rates, long-term visual prognosis rema

Mar 23, 2026
news

LISA MRS Formula Outperforms Existing Standards for IOL Calculation in Post-Refractive Surgery Patients, Especially in High Myopia

A new IOL power calculation formula, LISA MRS, demonstrates superior accuracy for cataract patients with prior myopic refractive surgery, significantly outperforming existing formulas in eyes with axial lengths of 28 mm or greater by utiliz

Mar 19, 2026
Clinical Updates

Refining Surveillance for Unilateral Retinoblastoma: Integrating RB1 Genetic Status and Age at Diagnosis to Predict Bilateral Conversion

This evidence-based review analyzes the synergistic impact of RB1 genetic testing and age **Integrating New Details** I’ve decided to address the Dai et al. study by broadening the scope to include a historical perspective on surveill

Mar 19, 2026
Clinical Updates

The Persistence of Ophthalmic Scarcity: A 23-Year Longitudinal Analysis of Drug Shortages in the United States

This review analyzes ophthalmic drug shortages from 2001 to 2024, revealing that eye medications face longer shortage durations than other drug classes, significantly influenced by patent status and manufacturing transparency.

Mar 18, 2026Sign in to read
Neurology

Navigating the Diagnostic Overlap: Why 24 Percent of Patients Meeting Minimal MS Criteria for Optic Neuritis Require Antibody Testing

A multicenter study reveals that nearly one-quarter of patients meeting the newest multiple sclerosis criteria for optic neuritis actually have MOGAD or NMOSD, emphasizing the critical role of antibody screening and detailed orbital MRI in

Mar 18, 2026Sign in to read
news

Microvascular Dropout as a Potent Biomarker for Structural Progression in Glaucoma Suspects

A retrospective cohort study reveals that microvascular dropout (MvD) and β-zone parapapillary atrophy (PPA) progression are significant independent predictors of structural optic disc damage in glaucoma suspect eyes, identifying risk long

Mar 16, 2026Sign in to read
Clinical Updates

Impact of Dual Sensory Impairment on Low Vision Rehabilitation: Navigating the Auditory-Visual Intersection

This clinical update examines the association between hearing impairment and visual rehabilitation outcomes, revealing that concurrent hearing loss significantly reduces the likelihood of functional improvement, independent of hearing aid u

Mar 16, 2026
news

Impact of Long-Term Intravitreal Anti-VEGF Injections on Cataract Progression and Surgical Outcomes

A longitudinal study of 603 patients demonstrates that chronic intravitreal anti-VEGF therapy significantly accelerates cataract development, particularly posterior subcapsular opacities, resulting in an eightfold increased risk for catarac

Mar 16, 2026Sign in to read
Neurology

High-Frequency TENS Shows Promise for Nociplastic Ocular Pain in Randomized Pilot Trial

This randomized pilot study demonstrates that high-frequency TENS significantly improves specific neuropathic ocular pain symptoms over three months, offering a non-invasive, non-pharmacological alternative for patients with refractory ocul

Mar 13, 2026
Allergy & Immunology

Institutional Policy Shifts on Penicillin Allergy Labels Dramatically Increase Cefuroxime Use in Cataract Surgery

A large-scale quality improvement study reveals that reclassifying penicillin allergies and providing pharmacy support can increase the use of intracameral cefuroxime from 2% to over 70%, significantly improving evidence-based prophylaxis i

Mar 13, 2026
Clinical Updates

Beyond the Cornea: Evaluating the Systemic Cardiometabolic Burden in Fuchs’ Endothelial Corneal Dystrophy

Recent data from the NIH All of Us Research Program indicates that Fuchs’ Endothelial Corneal Dystrophy (FECD) is associated with a significantly higher prevalence of cardiometabolic comorbidities, suggesting a systemic component to t

Mar 13, 2026
Superintelligence

Breaking the Hardware Barrier: How Domain-Shift AI Enables Vendor-Agnostic 3D OCT Macular Disease Detection

A multicenter study in JAMA Ophthalmology introduces a deep learning model using domain-shift technology to accurately detect macular diseases across different OCT hardware vendors, achieving high negative predictive value and establishing

Feb 27, 2026
Clinical Updates

Optimizing Glaucoma Management through Behavioral Intervention: Insights from the SEE Randomized Clinical Trial

The SEE randomized clinical trial demonstrates that a 6-month personalized coaching program using motivational interviewing significantly improves glaucoma medication adherence and reduces patient distress compared to standard education.

Feb 26, 2026
Superintelligence

Human-AI Collaboration Enhances Clinical Reasoning in Ophthalmology but Risks Overconfidence and Automation Bias

A crossover study involving 30 ophthalmologists and trainees reveals that while Claude-3.5-Sonnet collaboration improves diagnostic accuracy in complex cases, it also increases confidence in incorrect decisions and fails to reach the perfor

Feb 22, 2026
news

Rapid Fluid Resolution with Faricimab Predicts Long-Term Treatment Durability in nAMD

A post hoc analysis of the TENAYA and LUCERNE trials demonstrates that early resolution of retinal fluid by week 12 with faricimab is a significant predictor of achieving extended every-16-week dosing intervals in patients with neovascular

Feb 19, 2026Sign in to read
Previous
12 / 15
1…101112131415
Next

Go deeper with MedXY AI

Explore the evidence behind the news.

Ask AI
MedXY briefing

Stay informed

Medical news and research updates, delivered to your inbox.